Calmark participates in Swiss Nordic Bio 2021 on 10-11 February

Calmark participates in Swiss Nordic Bio 2021 on 10-11 February

Nyheter
News
Anna Söderlund, CEO at Calmark will participate at Swiss Nordic Bio 2021, which will be held in digital format with more than 300 participants and 100 investors. The event will be live streamed and 1-to-1 meetings will be held virtually.

Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investors and industry. The event carries 13 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. Business Sweden and Vator Securities are the co-hosts of this year’s digital version of this event.

"It will be very interesting to meet with European participants to assess how Calmark is perceived in an international investor context”, says Anna Söderlund, CEO. "In the private placement at the end of last year, several Danish and Norwegian actors chose to invest in Calmark and I look forward to welcoming more!”  

Find out more about the event: https://www.swissnordicbio.com